Company profile for SHIRE PLC

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

There’s a simple purpose that sits at the heart of our business: to enable people with life-altering conditions to lead better lives. This means we focus on developing treatments for conditions where the impact of our medicines can make an immediate and tangible difference for patients. We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal, and Internal Medicine. This might be a therapy to treat an extrem...
There’s a simple purpose that sits at the heart of our business: to enable people with life-altering conditions to lead better lives. This means we focus on developing treatments for conditions where the impact of our medicines can make an immediate and tangible difference for patients. We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal, and Internal Medicine. This might be a therapy to treat an extremely rare and life-threatening disease like Hunter syndrome or Fabry disease; or a medicine for a specialist condition like ADHD or ulcerative colitis which if not treated effectively, can dramatically affect

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
No. 99854 22 Grenville Street St Helier Jersey JE4 8PX
Telephone
Telephone
+353 1 429 7700
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com//news-release/2025/02/19/3028652/0/en/Immunocore-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-call-on-February-26-2025.html

GLOBENEWSWIRE
19 Feb 2025

https://www.globenewswire.com/news-release/2024/12/03/2990249/0/en/Immunocore-announces-reimbursement-agreement-in-England-for-KIMMTRAK-for-the-treatment-of-HLA-A-02-01-positive-adults-with-unresectable-or-metastatic-uveal-melanoma.html

GLOBENEWSWIRE
02 Dec 2024

https://www.globenewswire.com/news-release/2024/10/15/2962988/0/en/Co-Founder-of-Shire-Pharmaceuticals-Appointed-as-Chief-Operating-Officer-of-Klotho-Neurosciences.html

GLOBENEWSWIRE
15 Oct 2024

https://www.expresspharma.in/university-of-central-lancashire-partners-with-brinton-healthcare-uk-to-explore-nanoparticle-technology-for-skin-disease-treatment/

EXPRESSPHARMA
11 Oct 2024
Flemming mulls IPO for Galderma; Reistone shows results from eczema study
Flemming mulls IPO for Galderma; Reistone shows results from eczema study

11 Oct 2021

// Paul Schloesser\nAmber Tong ENDPTS

https://endpts.com/drawing-shire-parallel-flemming-ornskov-mulls-ipo-for-galderma-reistone-shows-results-from-eczema-study-with-jak1-blocker/

Paul Schloesser\nAmber Tong ENDPTS
11 Oct 2021

https://endpts.com/fda-offers-support-for-takedas-potential-cytomegalovirus-drug-ahead-of-adcomm/

Z. Brennan ENDPTS
07 Oct 2021

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty